Th17 response and its regulation in inflammatory upper airway diseases

Clinical and Experimental Allergy

Volumn 45, Issue 3, 2015, Pages 602-612

  Liu, Y ^a   Zeng, M ^a   Liu, Z ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUDESONIDE; CLARA CELL 10 KDA PROTEIN; CORTICOSTEROID; DESIPRAMINE; FORMOTEROL; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR BETA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOGLYCAN RECOGNITION PROTEIN; PROSTAGLANDIN SYNTHASE; PROTEIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAPHYLOCOCCUS ENTEROTOXIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; CYTOKINE; MANNAN; MANNOBIOSE; SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN;

ALLERGIC RHINITIS; ASTHMA; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RHINOSINUSITIS; CYTOLOGY; DISEASE ASSOCIATION; EOSINOPHIL; GENE EXPRESSION; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; POLLEN ALLERGY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE; TH17 CELL; UPPER RESPIRATORY TRACT INFECTION; ANIMAL; BACTERIUM; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOMODULATION; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; RHINITIS; RHINITIS, ALLERGIC; SIGNAL TRANSDUCTION; SINUSITIS; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANIMALS; ANTIDEPRESSIVE AGENTS; BACTERIA; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOMODULATION; IMMUNOTHERAPY; MANNANS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RHINITIS; RHINITIS, ALLERGIC; SIGNAL TRANSDUCTION; SINUSITIS; T-LYMPHOCYTE SUBSETS; TH17 CELLS; UTEROGLOBIN;

EID: 84923421630     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12378     Document Type: Review

References (92)

1. Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 2013; 8:477-512.
2. Moverare R, Elfman L, Stalenheim G, Bjomsson E. Study of the Th1/Th2 balance, including IL-10 production, in culture of peripheral blood mononuclear cells from birch-pollen-allergic patients. Allergy 2000; 55:171-5.
3. Bousquet J, Khaltaev N, Cruz AA et al. Allergic rhinitis and its impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(Suppl 86):8-160.
4. Ciprandi G, De Amici M, Murdaca G et al. Serum IL-17 levels are related with clinical severity in allergic rhinitis. Allergy 2009; 64:1375-8.
5. Ma F, Xu S, Liu X et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol 2011; 24:861-9.
6. Wallner M, Hauser M, Himly M et al. Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol 2011; 127:1571-8.
7. Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013; 13:666-78.
8. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008; 57:121-34.
9. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11:7-13.
10. Liston A, Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 2014; 14:154-65.
11. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 2003; 19:165-8.
12. Lousten J, Boniface K, de Waal Malefyt R. Development and function of Th17 cells in health and disease. J Allergy Clin Immunol 2009; 123:1004-11.
13. Schmidt-Weber CB, Akdis M, Akdis CA. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120:247-54.
14. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-98.
15. + regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol 2007; 191:51-60.
16. Lexberg MH, Taubner A, Förster A et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008; 38:2654-64.
17. + T cell lineage differentiation. Immunity 2009; 30:646.
18. Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 2009; 21:274-80.
19. Yao C, Sakata D, Esaki Y et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009; 15:633-40.
20. Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:1090-100.
21. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60:1647-56.
22. Toosi S, Bystryn JC. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid. Med Hypotheses 2010; 74:727-8.
23. Ishizu T, Osoegawa M, Mei FJ et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005; 128:988-1002.
24. Roussel L, Houle F, Chan C et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010; 184:4531-7.
25. Fujisawa T, Chang MM, Velichko S et al. NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol 2011; 45:246-52.
26. Newcomb DC, Peebles R Jr. Th17-mediated inflammation in asthma. Curr Opin Immunol 2013; 25:755-60.
27. Chen G, Zhang X, Li R et al. Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum 2010; 62:2900-8.
28. Tanaka J, Watanabe N, Kido M et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 2009; 39:89-100.
29. Spadoni I, Iliev ID, Rossi G, Rescigno M. Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis. Mucosal Immunol 2012; 5:184-93.
30. Levy BD. Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways. Front Immunol 2012; 3:390.
31. Maneechotesuwan K, Kasetsinsombat K, Wamanuttajinda V, Wongkajornsilp A, Barnes PJ. Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells. Clin Exp Allergy 2013; 43:212-22.
32. Nakagome K, Imamura M, Okada H et al. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol 2011; 186:5975-82.
33. Laumonnier Y, Schmudde I, Köhl J. The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma. Curr Allergy Asthma Rep 2011; 11:122-30.
34. Park SY, Jing X, Gupta D, Dziarski R. Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses. J Immunol 2013; 190:3480-92.
35. Kariyawasam HH, Rotiroti G. Allergic rhinitis, chronic rhinosinusitis and asthma: unravelling a complex relationship. Curr Opin Otolaryngol Head Neck Surg 2013; 21:79-86.
36. Quan SH, Zhang YL, Han DH, Iwakura Y, Rhee CS. Contribution of interleukin-17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann Allergy Asthma Immunol 2012; 108:342-50.
37. Farfariello V, Amantini C, Nabissi M et al. IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients. Pediatr Allergy Immunol 2011; 22:419-23.
38. Malakauskas K, Lavinskiene S, Jeroch J et al. Response of peripheral blood Th17 cells to inhaled Dermatophagoides pteronyssinus in patients with allergic rhinitis and asthma. Lung 2012; 190:487-95.
39. Liu Y, Yu HJ, Wang N et al. Clara cell 10-kDa protein inhibits TH17 responses through modulating dendritic cells in the setting of allergic rhinitis. J Allergy Clin Immunol 2013; 131:387-94.
40. Wang M, Zhang Y, Han D, Zhang L. Association between polymorphisms in cytokine genes IL-17A and IL-17F and development of allergic rhinitis and comorbid asthma in Chinese subjects. Hum Immunol 2012; 73:647-53.
41. Wang M, Zhang W, Shang J, Yang J, Zhang L, Bachert C. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis. Clin Exp Allergy 2013; 43:956-66.
42. Halwani R, Al-Muhsen S, Hamid Q. T helper 17 cells in airway diseases: from laboratory bench to bedside. Chest 2013; 143:494-501.
43. Tang H, Wang H, Bai J et al. Sensitivity of MUC5AC to topical corticosteroid is negatively associated with interleukin-17A in patients with allergic rhinitis. Am J Rhinol Allergy 2012; 26:359-64.
44. Frenzel DF, Weiss JM. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy. Expert Rev Clin Immunol 2011; 7:93-109.
45. Wang H, Liu Y, Liu Z. Clara cell 10-kD protein in inflammatory upper airway diseases. Curr Opin Allergy Clin Immunol 2013; 13:25-30.
46. McKinley L, Alcorn JF, Peterson A et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181:4089-97.
47. Qu SH, Li M, Huang YJ et al. Effects of allergen and intranasal glucocorticoid on Th17 and RORgamma t in peripheral blood in patients with allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009; 44:996-1000.
48. Albano GD, Di Sano C, Bonanno A et al. Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach. PLoS ONE 2013; 8:588-92.
49. Kovacs-Nolan J, Kanatani H, Nakamura A, Ibuki M, Mine Y. β-1, 4-mannobiose stimulates innate immune responses and induces TLR4-dependent activation of mouse macrophages but reduces severity of inflammation during endotoxemia in mice. J Nutr 2013; 143:384-91.
50. Yang C, Rupa P, Kanatani H, Nakamura A, Ibuki M, Mine Y. Therapeutic effects of β1, 4 mannobiose in a Balb/c mouse model of intranasally-induced pollen allergy. Allergol Int 2013; 62:65-76.
51. Ibuki M, Fukui K, Kanatani H, Mine Y. Anti-inflammatory effects of mannanase-hydrolyzed copra meal in a porcine model of colitis. J Vet Med Sci 2014; 76:645-51.
52. Chen MH, Su TP, Chen YS et al. Allergic rhinitis in adolescence increases the risk of depression in later life: a nationwide population-based prospective cohort study. J Affect Disord 2013; 145:49-53.
53. Zhang Y, Zhen H, Yao W et al. Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells. Int J Immunopathol Pharmacol 2013; 26:107-15.
54. Nutsch KM, Hsieh CS. T cell tolerance and immunity to commensal bacteria. Curr Opin Immunol 2012; 24:385-91.
55. Doz E, Lombard R, Carreras F, Buzoni-Gatel D, Winter N. Mycobacteria-infected dendritic cells attract neutrophils that produce IL-10 and specifically shut down Th17 CD4 T cells through their IL-10 receptor. J Immunol 2013; 191:3818-26.
56. Heydenreich B, Bellinghausen I, König B et al. Gram-positive bacteria on grass pollen exhibit adjuvant activity inducing inflammatory T cell responses. Clin Exp Allergy 2012; 42:76-84.
57. Kim YS, Choi EJ, Lee WH et al. Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses. Clin Exp Allergy 2013; 43:443-54.
58. Gangl K, Niederberger V, Valenta R. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin Exp Allergy 2013; 43:1202-16.
59. Li CW, Lu HG, de Chen H, Lin ZB, Wang DY, Li TY. In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients. PLoS ONE 2014; 19:e91950.
60. Van Bruaene N, Pérez-Novo CA, Basinski TM et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121:1435-41.
61. Shi LL, Xiong P, Zhang L et al. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy 2013; 68:101-9.
62. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124:478-84.
63. Derycke L, Zhang N, Holtappels G, Dutré T, Bachert C. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J Cyst Fibros 2012; 11:193-200.
64. Makihara S, Okano M, Fujiwara T et al. Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation. J Allergy Clin Immunol 2010; 126:397-400.
65. Jiang XD, Li GY, Li L, Dong Z, Zhu DD. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2011; 25:e171-5.
66. Saitoh T, Kusunoki T, Yao T et al. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int Arch Allergy Immunol 2010; 151:8-16.
67. Kim DW, Khalmuratova R, Hur DG et al. Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model. Am J Rhinol Allergy 2011; 25:e255-61.
68. Tantilipikorn P, Bunnaq C, Nan Z, Bachert C. Staphylococcus aureus superantigens and their role in eosinophilic nasal polyp disease. Asian Pac J Allergy Immunol 2012; 30:171-6.
69. Yu J, Oh MH, Park JU et al. Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS ONE 2012; 7:e39032.
70. Roca-Ferrer J, Garcia-Garcia FJ, Pereda J et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol 2011; 128:66-72.
71. Carey MA, Germolec DR, Bradbury JA et al. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. Am J Respir Crit Care Med 2003; 167:1509-15.
72. Chizzolini C, Chicheportiche R, Alvarez M et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008; 112:3696-703.
73. + T cells. Eur J Immunol 2009; 39:1301-12.
74. Abdelmegeed E, Shaaban MI. Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J Microbiol 2013; 51:598-604.
75. Kou W, Hu GH, Yao HB et al. Transforming growth factor-β1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment. Inflamm Res 2013; 62:283-9.
76. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003; 113:1803-12.
77. Wen W, Liu W, Zhang L et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 2012; 129:1522-8.
78. Zaghi D, Krueger GG, Callis Duffin K. Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis. J Drugs Dermatol 2012; 11:160-7.
79. Khanna R, Feagan BG. Ustekinumab for the treatment of Crohn's disease. Immunotherapy 2013; 5:803-15.
80. Genovese MC, Van den Bosch F, Roberson SA et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, doubleblind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010; 62:929-39.
81. Chang H, Wang Y, Wu W, Li G, Hanawa H, Zou J. Hydrodynamics-based delivery of an interleukin-1 receptor II fusion gene ameliorates rat autoimmune myocarditis by inhibiting IL-1 and Th17 cell polarization. Int J Mol Med 2013; 31:833-40.
82. Paul-Pletzer K. Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs Today (Barc) 2006; 42:559-76.
83. Hagino N, Yamaguchi K, Ohara Y. Tocilizumab for systemic juvenile idiopathic arthritis. N Engl J Med 2013; 368:1256.
84. Huh JR, Littman DR. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur J Immunol 2012; 42:2232-7.
85. Wu J, Zhou C, Chen W et al. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity. Transplantation 2013; 95:434-41.
86. Solt LA, Kumar N, Nuhant P et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011; 472:491-4.
87. McAllister F, Henry A, Kreindler JL et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175:404-12.
88. Laan M, Lötvall J, Chung KF, Lindén A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001; 13:200-6.
89. Uyttenhove C, Sommereyns C, Théate I, Michiels T, Van Snick J. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 2007; 1110:330-6.
90. Zhang Y, Ren G, Guo M et al. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. Int Immunopharmacol 2013; 15:199-205.
91. Schnyder-Candrian S, Togbe D, Couillin I et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006; 203:2715-25.
92. Li J, Simeoni E, Fleury S et al. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur J Cardiothorac Surg 2006; 29:779-83.